Skip to content
Ryan Smith, DDS

Clinical · Endodontics

AAE position statement on vital pulp therapy (2021): a pretreatment diagnosis of irreversible pulpitis is not automatically a root canal

The AAE's 2021 statement puts vital pulp therapy on the table for mature permanent teeth with carious exposure, where only root canal or extraction used to be. Complete caries removal, sodium hypochlorite hemostasis, direct inspection of the pulp under magnification, a calcium silicate cement, and an immediate restoration.

Clinical guidelines and evidence

Issued by

American Association of Endodontists

2021

Status
current
Source
aae.org
Last read
2026-09-13
Six tiles in sequence. One, diagnose: normal, reversible pulpitis or irreversible pulpitis are the three vital categories, and cold and electric pulp testing are sensibility tests rather than vitality tests. Two, remove all the caries: complete removal of demineralized enamel and infected dentin, because residual caries hides the inflammation you are trying to read. Three, hemostasis and inspection: sodium hypochlorite on the resected pulp, typically 5 to 10 minutes, with assessment under magnification and a surgical microscope recommended. Four, marked in coral, the decision: how much pulp comes out follows the tissue assessment rather than the pretreatment label, and the options are indirect or direct cap, partial or full pulpotomy, or pulpectomy. Five, biomaterial: MTA and other calcium silicate cements at 85 to 100 percent success at 1 to 2 years, against 43 to 92 percent for calcium hydroxide, glass ionomer and resin materials. Six, restore immediately, which the statement calls a strong predictor of success, waiting before preparing for cuspal coverage. Below, a strip of outcome numbers from the Ather 2022 meta-analysis of 11 studies: 86 percent pooled success, 78.6 percent after adjusting for publication bias, open apex 96 percent against closed apex 83 percent, and GRADE certainty very low.
The sequence the position statement describes, from diagnosis to restoration, with the independent pooled outcome figures underneath. Wording condensed from the AAE statement and from Ather et al. 2022. Illustration, not clinical advice.Open full size
success at 1 to 2 years with MTA and other calcium silicate cements in permanent teeth with symptomatic or asymptomatic irreversible pulpitis
85% to 100%
success with calcium hydroxide, glass ionomer cements and resin-based materials, which the statement says trail in clinical outcomes
43% to 92%
of sodium hypochlorite on the resected pulp is the typical hemostasis time the statement describes, though it notes recommended durations vary
5 to 10 minutes
pooled pulpotomy success for carious irreversible pulpitis in an independent 2022 meta-analysis of 11 studies, graded very low certainty
86%

Covered

3
  • Permanent teeth with a vital pulp injured by trauma, caries or restorative procedures, including mature teeth previously thought to have irreversibly inflamed pulps, for which only root canal therapy or extraction used to be considered
  • The traditional procedures it names: indirect and direct pulp capping, and partial or complete pulpotomy, together with diagnostic considerations, caries management, pulp management, biomaterial placement and restoration
  • Written from the perspective of specialty endodontics, but the AAE says it may be of use to any practitioner in assessing whether they have the appropriate expertise and armamentarium to perform vital pulp therapy in appropriately selected cases

Not covered

3
  • It grades nothing. There is no GRADE scheme, no strength of recommendation and no certainty rating anywhere in it; it is a narrative statement with 96 references, and a 2025 AGREE II appraisal of four vital pulp therapy documents put the European Society of Endodontology statement highest overall
  • Its own disclaimer: the guidance is not intended to substitute for a clinician's independent judgment in light of the conditions and needs of a specific patient
  • It does not cover primary teeth, regenerative endodontics, or nonsurgical root canal treatment itself; the AAE Treatment Standards white paper, covered separately in this directory, names vital pulp therapy as part of the specialty but outside the standards it sets

Timeline

  1. 2009

    1. 2009

      Levin, Law, Holland and colleagues publish the AAE consensus diagnostic terms for pulpal health and disease (J Endod 2009;35:1645-1657), the three vital categories the statement works from

  2. 2019

    1. 2019

      The European Society of Endodontology publishes its position statement on management of deep caries and the exposed pulp (Int Endod J 2019;52:923-934)

  3. 2020

    1. 2020

      AAE Glossary of Endodontic Terms, tenth edition, the statement's first reference

  4. 2021

    1. May 24

      AAE news release: a dedicated special committee of the AAE based its recommendations on recent studies showing a high rate of success in properly selected cases

    2. Sep

      Published in the Journal of Endodontics, volume 47, issue 9, pages 1340 to 1344

  5. 2022

    1. Nov

      Ather and colleagues publish a systematic review and meta-analysis of pulpotomy outcomes in Scientific Reports, the first to pool them with predictors of success

  6. 2025

    1. 2025Latest

      An AGREE II and AGREE-REX appraisal of four vital pulp therapy guidelines (ESE 2019, GSEDT 2019, AAE 2021, ADA 2021) reports the ESE statement scoring highest overall

What it says

Vital pulp therapy is the set of techniques that keep an injured pulp alive: indirect and direct pulp capping, and partial or complete pulpotomy. For years the point of it was apexogenesis, keeping the radicular pulp alive in an immature tooth long enough for the root to finish forming. The AAE's 2021 statement widens that. Practitioners, it says, may have options other than pulpectomy or root canal therapy in mature teeth, including teeth previously thought to have irreversibly inflamed pulps. The AAE's own news release puts the change plainly: previously only root canal therapy or extraction may have been considered for adult teeth with injured pulps and fully formed roots.

The diagnostic argument comes first. The current AAE terminology assigns a vital pulp to normal, reversible pulpitis, or irreversible pulpitis, symptomatic or asymptomatic. The statement then undercuts the weight that label carries. Cold and electric pulp tests are, in its words, best termed pulp sensibility tests, because definitive tests of pulp vitality such as pulp oxygen tension are not available for clinical use. Clinical test results have long been known to correlate poorly with histology. Histologic evidence of the progression of pulpitis suggests there is no discrete boundary that would render a pulp beyond repair, and some authors have proposed grading pulpitis as initial, mild, moderate and severe instead. Until molecular tests arrive, the statement says direct observation of the pulp, with a surgical microscope recommended, is what gives the relevant information: it identifies a misdiagnosed necrotic pulp, and the appearance of the tissue during and after hemostasis says whether the case is suitable.

Caries removal is the part that will surprise a general dentist who has been reading the selective-excavation literature. The statement is unequivocal: complete caries removal is essential, and predictable management of vital pulp tissue should not be performed without complete removal of both demineralized enamel and infected dentin. Its reasoning is that residual caries compromises the observation of inflammation and necrosis that the whole approach depends on, that histobacteriological studies consistently show chronic inflammatory infiltrate and subclinical pulp inflammation where carious tissue is retained, and that bond strengths to sound dentin beat those to caries-affected dentin. Caries detector dyes and laser fluorescence are named as helpful adjuncts. The framing is deliberate: the clinician should focus on complete removal of demineralized infected dentin rather than on avoiding a pulp exposure.

Then hemostasis. Sodium hypochlorite gives hemostasis, disinfects the dentin-pulp interface, removes biofilm, chemically removes the blood clot and fibrin, and clears dentinal chips and damaged cells from the exposure. Hemostasis is typically achieved by bathing the resected pulp tissue in sodium hypochlorite for 5 to 10 minutes, by direct passive irrigation or on a soaked cotton pellet, although the statement notes that recommended durations vary. It can be used safely in direct contact with pulp at concentrations from dilute to full bottle strength, and has not been shown to adversely alter pulp cell recruitment, cytodifferentiation or hard tissue deposition.

On materials, calcium silicate cements (tricalcium and dicalcium silicates, hydraulic calcium silicate cements and bioceramics) are the class that has gained momentum, with MTA the most extensively studied. When MTA and other calcium silicate cements are used for vital pulp therapy in permanent teeth with symptomatic or asymptomatic irreversible pulpitis, success rates range from 85% to 100% at 1 to 2 years. Calcium hydroxide, glass ionomer cements and resin-based materials trail, at 43% to 92%. The mineralized barriers calcium silicates form are described as better in quality than those from calcium hydroxide, and newer generations set faster and discolor less.

Restoration closes it. Immediate restoration should be part of the restorative treatment plan for a tooth receiving vital pulp therapy; teeth sealed with a calcium silicate cement and restored immediately with a long-term restoration have a high success rate, and a minimal time span between the procedure and a foundational restoration is described as a strong predictor of success. No negative impact of restoring immediately has been shown. Before preparing the tooth for definitive cuspal coverage, the statement asks for an appropriate waiting period and a judgment on symptoms and fracture susceptibility.

The summary is where the statement earns its place in a general practice. The amount of pulp removed or retained depends on tissue viability assessments based on access for visualization, hemorrhage control and clinical tissue appearance. A pretreatment diagnosis of irreversible pulpitis is not necessarily an indication for pulpectomy. And the AAE calls for more clinical trials on long-term outcomes, chairside biomarkers, and a review of the endodontic diagnostic terminology used to classify pulpal disease severity.

Nothing in the statement is graded. For certainty ratings you have to go outside it: Ather and colleagues pooled 11 studies of pulpotomy in permanent teeth with carious irreversible pulpitis, minimum six-month follow-up, and reported 86% success (95% CI 0.76 to 0.92, I-squared 81.9%), falling to 78.6% (95% CI 0.66 to 0.87) after trim-and-fill adjustment for publication bias, which Egger's test suspected. Open apex teeth did better than closed apex (96% against 83%, p = 0.02); symptomatic and asymptomatic cases did not differ significantly (84% against 91%, p = 0.18); Biodentine beat MTA, calcium hydroxide and calcium-enriched mixture. The authors graded the certainty of all of it very low.

From the document

A pretreatment diagnosis of irreversible pulpitis is not necessarily an indication for pulpectomy, as more conservative treatment could be considered.
Summary section of the position statement

Who it applies to

Any dentist who opens a deep carious lesion in a permanent tooth. The statement is written from the perspective of specialty endodontics, and says so, but adds that it may be useful to any practitioner in assessing whether they have the appropriate expertise and armamentarium. The armamentarium is the real gate: magnification, ideally a microscope, a working knowledge of sodium hypochlorite on pulp tissue, a calcium silicate cement on the shelf, and the time in the schedule to place a definitive restoration at the same visit.

It does not cover primary teeth, regenerative procedures or root canal treatment itself, and it carries the AAE's standard disclaimer that it does not substitute for clinical judgment about a specific patient. It is not a guideline in the methodological sense: a 2025 AGREE II and AGREE-REX appraisal of four vital pulp therapy documents (the ESE 2019, the German society's 2019, the AAE's 2021 and the Australian Dental Association's 2021) reported that the ESE statement scored highest overall and called for better rigor of development and applicability across the set.

What changed

Two things. The first is the indication. Before this statement, an AAE-aligned dentist treated "irreversible pulpitis" as a root canal diagnosis, because that is how the 2009 consensus terminology defined it. The statement does not rewrite the terminology, but it detaches the treatment from the label and asks for a review of the terminology itself.

The second is caries removal, and here the AAE moves in the opposite direction from most of the restorative literature. The trend in caries management has been toward selective removal and leaving affected dentin over the pulp. The AAE says that when you intend to treat the pulp, you remove everything demineralized and infected, and you stop trying to avoid the exposure. Both positions can be true, because they answer different questions. My own view: the deciding factor in the office is what you are planning to do next. If the plan is a restoration and you are happy leaving a leathery floor under a bonded liner, that is selective excavation. If the plan is vital pulp therapy, this statement says you cannot judge the pulp through the caries you left.

What to do in the practice

0 of 7 done

Ticks are saved in this browser only.

Where the source is

The link under the title is the AAE's own PDF, AAE Position Statement, Vital Pulp Therapy, ten pages, copyright 2021 American Association of Endodontists, hosted on aae.org; it was downloaded and read in full for this entry. The same text was printed in the Journal of Endodontics 2021, volume 47, issue 9, pages 1340 to 1344, where PubMed indexes it (PMID 34352305) without an abstract. The AAE's news release of May 24, 2021 records that a dedicated special committee developed the recommendations. Note that aae.org refuses automated download tools and answers them with a 403; its documents open normally in a browser. The pooled outcome figures quoted here are not the AAE's: they come from Ather, Patel, Gelfond and Ruparel in Scientific Reports 2022, which is open access under CC BY and was read in full on Europe PMC. The AGREE II appraisal is Sachdeva and colleagues, Evidence-Based Dentistry 2025, read here from its PubMed abstract only.

AAEendodonticsposition statementroot canalcariesrestorative materialstreatment planningevidence

This page summarizes a published rule or document for dentists. The document itself governs; read it before you act on it, and check with counsel where a rule touches your state.

The Dental Grind

Every Monday, free: how a practice actually works, plus the podcast.